PulmonologyNews.net

Pulmonology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Pseudomonas aeruginosa"

Infections with the bacteria Pseudomonas are a major cause of sickness and death in cystic fibrosis patients. " Pseudomonas can use the remnants of dead white blood cells to develop a protective b ...


Researchers at University of California - Irvine ( UCI ) have found that breath-analysis testing may prove to be an effective, non-invasive method for detecting the damaging lung-bacteria growth seen ...


It has been known for some time that the bacterium, Pseudomonas aeruginosa, grows within the deadly, lung-clogging mucous found in the airways of cystic fibrosis patients and significantly weakens the ...


It has been known for some time that the bacterium, Pseudomonas aeruginosa, grows within the deadly, lung-clogging mucous found in the airways of cystic fibrosis patients and significantly weakens the ...


Mannose-binding lectin ( MBL ) is a key component of innate immunity. MBL deficiency is common ( 10-30% of the general population depending on the definition used ) and has been associated with diseas ...


Respiratory pathogens are frequently isolated from the airways in patients with chronic obstructive pulmonary disease ( COPD ) in the absence of an exacerbation. This bacterial colonization by potenti ...


Long-term macrolide treatment has proven benefit in inflammatory airways diseases, but whether it leads to changes in the composition of respiratory microbiota is unknown. A study aimed to assess wh ...


Multidrug-resistant ( MDR ) bacteria are a growing concern worldwide. The aim of this study was to describe the epidemiology and risk factors of MDR bacteria detected in respiratory invasive samples d ...


No prospective study has assessed eradication treatment of early Pseudomonas aeruginosa ( P. aeruginosa ) colonisation in bronchiectasis not due to cystic fibrosis. Researchers have evaluated the e ...


Eradication and suppression of Pseudomonas aeruginosa ( P. aeruginosa ) is a key priority in national guidelines for bronchiectasis, and is a major focus of drug development and clinical trials. An ac ...